FDA inspectors found black mold on equipment, significant insect activity in ceilings, and other egregious conditions at two Chinese factories producing active ingredients for compounded GLP-1 drugs. American pharma companies are putting U.S. citizens at risk by depending on China to produce medicine. bloomberg.com/news/articles/…